Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00198198 · ClinicalTrials.gov registry record · Phase 4
Aripiprazole Treatment of Bipolar Depression
A Phase 4 study of Bipolar Depression, sponsored by Indiana University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00198198 is a Phase 4 study of Bipolar Depression that has completed, run by Indiana University School of Medicine. The registered enrollment target is 10 participants, below the 216-participant average among 29 other Bipolar Depression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00198198, a Phase 4 study of Bipolar Depression, has completed, sponsored by Indiana University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study of addition of aripirazole to the treatment of bipolar depressed patients who are not better on the medications that they are currently receiving.
Conditions Studied
Interventions
- DRUG Aripiprazole
Study Locations (1)
Indiana
- UH 3124 University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00198198
The ClinicalTrials.gov registry entry for NCT00198198 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 216-participant average among 29 other Bipolar Depression trials with a reported enrollment target (95% lower). The listed sponsor is Indiana University School of Medicine, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bipolar Depression appearing as the primary indexed condition, and to 1 intervention - of which Aripiprazole is the first listed.
NCT00198198 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT00198198 about?
NCT00198198 is a clinical study titled "Aripiprazole Treatment of Bipolar Depression". This is a study of addition of aripirazole to the treatment of bipolar depressed patients who are not better on the medications that they are currently receiving.
What is the current status of trial NCT00198198?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2005-08. Estimated completion is 2006-11.
What conditions does trial NCT00198198 study?
This clinical trial studies the following conditions: Bipolar Depression.
What interventions are being tested in trial NCT00198198?
The interventions under investigation include: Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT00198198?
This trial is sponsored by Indiana University School of Medicine, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00198198 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
RECRUITING · Phase 4
-
Minocycline for Bipolar Depression
COMPLETED · Phase 4
-
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
RECRUITING · Early Phase 1
-
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
RECRUITING · Phase 3
-
University of Iowa Interventional Psychiatry Service Patient Registry
RECRUITING
-
Ketogenic Intervention for Bipolar Depression
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.